MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02236nam a22002417a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KENaKMTC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240523073645.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240523b ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323930727 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
dlc |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM301.2.S55 2023 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Relator code |
Skidmore-Roth, Linda. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Mosby's 2023 nursing drug reference: |
| Statement of responsibility, etc |
Compiled by Linda Skidmore-Roth |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
36th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Elsevier, St. Louis: |
| Name of publisher, distributor, etc |
Missouri, |
| Date of publication, distribution, etc |
c2023 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
x, 1490 p.:(5 unnumbered pages) ; |
| Other physical details |
ill, |
| Dimensions |
19 cm |
| 500 ## - GENERAL NOTE |
|---|
| General note |
previously published as 36th ed., in 2023. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
INDIVIDUAL DRUG MONOGRAPHSAPPENDIXESA. Selected New Drugsabametapiraducanumab-avwaafamelanotideanifrolumab-fniaasciminibatogepantavacopanavapritinibbelumosudilbelzutifanbempedoic acidbrolucizumab-dblldifelikefalindostarlimab-gxlyeculizumabefavirenz/emtricitabine/tenofovirelapegademase-ivirelbasvir/grazoprevirelexacaftor/tezacaftor/ivacaftor and ivacaftoremtricitabine/rilpivirine/tenofovir alafenamideenalapril/hydrochlorothiazideephedrinefactor IX complexfactor IX, humanfactor IX, recombinantfinerenonefluocinolonefluocinonidelonapegsomatropin-tcgdloncastuximab tesirine-lpylmaribavirmobocertinibodevixibatropeginterferon alfa-2btisotumab vedotin-tftvvosoritideB. Ophthalmic, Nasal, Topical, and Otic ProductsC. Vaccines and ToxoidsD. Recent FDA Drug ApprovalsINDEXEVOLVE WEBSITE. Additional Monographs. Drug Categories |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2023 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled -- including 35 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="Uniform resource identifier.">Uniform resource identifier.</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Reference |
| Intials |
NJW. |
